HIV/HCV co-infection: clinical and therapeutic challenges.
Fabrizio
F
Ensoli
Maria Caterina
MC
Sirianni
D023241:Antiretroviral Therapy, Highly Active; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D056486:Chemical and Drug Induced Liver Injury; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006526:Hepatitis C / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008107:Liver Diseases / Q000473:pathology; D011480:Protease Inhibitors / Q000009:adverse effects; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects
D000998:Antiviral Agents; D011480:Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors